Cara Therapeutics | CARA - Market Capitalization


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Cara Therapeutics

Cara Therapeutics reported $173.5M in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 3.05B 475M
Cara Therapeutics CARA:US USD 265M 312M
Chugai Pharma 4519:JP JPY 5.49T 164.55B
Depomed DEPO:US USD 355M 147M
Endo International ENDP:US USD 17M 0
Halozyme Therapeutics HALO:US USD 5.17B 2.52B
Horizon Pharma HZNP:US USD 24.93B 895M
J&J JNJ:US USD 402.75B 59.1B
Neurocrine Biosciences NBIX:US USD 9.87B 1.61B
Pacira PCRX:US USD 1.88B 103M
Pfizer PFE:US USD 230.29B 57.33B
RedHill Biopharma RDHL:US USD 13M 19M
Revance Therapeutics RVNC:US USD 2.7B 1.18B
Supernus Pharmaceuticals SUPN:US USD 1.97B 42M
Vanda Pharmaceuticals VNDA:US USD 386M 32M